Can you interpret the DXA results and advise management for a 70‑year‑old patient with lumbar spine T‑score –0.6 (normal), left femoral neck T‑score –1.4 (osteopenia), left total‑hip T‑score –0.1 (normal), and FRAX 10‑year major osteoporotic fracture risk 4.4% and hip fracture risk 0.5%?

DXA Interpretation and Management Recommendation

This 70-year-old patient does NOT require pharmacological treatment for osteoporosis at this time, but should continue non-pharmacological interventions including calcium, vitamin D supplementation, and weight-bearing exercise. 1

Key Findings Summary

Your DXA results show:

• Lowest T-score: -1.4 (left femoral neck) = Osteopenia
• FRAX 10-year risks: 4.4% major osteoporotic fracture, 0.5% hip fracture
• Positive trend: Significant improvements in both femoral neck (+5.8%) and total hip (+7.3%) from prior scan

Treatment Threshold Analysis

You do not meet criteria for pharmacological treatment because all three National Osteoporosis Foundation thresholds are negative 1:

1. ✗ No hip or vertebral fracture
2. ✗ T-score is -1.4 (not ≤ -2.5)
3. ✗ FRAX scores below treatment thresholds:
   • Major osteoporotic fracture: 4.4% (need ≥ 20%)
   • Hip fracture: 0.5% (need ≥ 3%)

The 2022 ACR guidelines 1 and your radiology report correctly identify that you fall well below the FRAX treatment thresholds, which are the most evidence-based criteria for initiating pharmacotherapy in patients with osteopenia.

Important Clinical Context

Why Both Hips Matter

Your scan appropriately measured both hips. Research demonstrates that 10% of patients have discordant treatment recommendations between left and right hips 2, and the dominant leg hip typically shows lower BMD 3. Your left femoral neck T-score of -1.4 represents your worst measurement and correctly drives clinical decision-making.

The Improving Trend is Reassuring

The 5.8% increase in femoral neck BMD and 7.3% increase in total hip BMD are clinically significant improvements. This positive trajectory suggests your current non-pharmacological interventions are working effectively.

Age-Related Considerations

At age 70, your Z-scores are all positive (ranging from +0.3 to +1.4), meaning your bone density is actually above average compared to age-matched peers. The T-score compares you to young healthy adults, while the Z-score provides age-appropriate context 1.

Recommended Management Plan

Continue current approach:

• Calcium and vitamin D supplementation
• Weight-bearing and muscle-strengthening exercise
• Fall prevention strategies
• Repeat DXA in 1-2 years at the same facility 1

Monitor for changes in risk factors that would trigger reassessment:

• New fragility fracture (would immediately warrant treatment regardless of BMD)
• Initiation of glucocorticoids
• Development of secondary causes of bone loss
• Significant decline in BMD on next scan

Critical Pitfall to Avoid

Do not treat based on the osteopenia label alone. The 2025 USPSTF guidelines 4 emphasize that most fragility fractures occur in people without osteoporosis (T-score > -2.5), but this doesn't mean all osteopenia requires medication. Treatment decisions must integrate absolute fracture risk via FRAX, not just BMD categories. Your FRAX scores of 4.4% and 0.5% place you in a low-risk category where harms of pharmacotherapy would likely outweigh benefits.

The improving BMD trend is particularly important—starting bisphosphonates when bone density is already increasing naturally would be premature and potentially expose you to unnecessary medication risks.